Long-term effects of the mean hemoglobin A1c levels after percutaneous coronary intervention in patients with diabetes
Jaekyung Bae, Ji-Hyung Yoon, Jung-Hee Lee, Jong-Ho Nam, Chan-Hee Lee, Jang-Won Son, Ung Kim, Jong-Seon Park, Dong-Gu Shin
Korean J Intern Med. 2021;36(6):1365-1376. Published online 2021 Oct 14 DOI: https://doi.org/10.3904/kjim.2020.694
Citations to this article as recorded by 
Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus
Irene Santos-Pardo, Mikael Andersson Franko, Bo Lagerqvist, Viveca Ritsinger, Björn Eliasson, Nils Witt, Anna Norhammar, Thomas Nyström
Journal of the American College of Cardiology.2024; 84(3): 260. CrossRef
Impact of Duration of Diabetes Mellitus on Long-Term Outcome in Type 2 Diabetic Patients with Primary Percutaneous Coronary Intervention after the First Myocardial Infarction
Nazila Yaliqin, Salamaiti Aimaier, Dilare Adi, Yi-Tong Ma, Zi-Xiang Yu
Cardiology.2024; 149(4): 297. CrossRef
Achievement of the ESC recommendations for secondary prevention of cardiovascular risk factors in high-risk patients with type 2 diabetes: A real-world national cohort analysis
Ahmed M. Salem, Daniel Harris, Jonathan J.H. Bray, Daniel R. Obaid, Jeffrey W. Stephens, Julian Halcox
International Journal of Cardiology.2023; 377: 104. CrossRef
Is Lower Better?
Mario Gaudino, David Chadow, Roberto Perezgrovas
JACC: Asia.2022; 2(2): 207. CrossRef
Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus
Jeongmin Lee, Jae-Seung Yun, Seung-Hyun Ko
Nutrients.2022; 14(15): 3086. CrossRef
Optimizing glucose control for diabetic patients undergoing percutaneous coronary intervention
Haseong Chang, Sung-Hea Kim
The Korean Journal of Internal Medicine.2021; 36(6): 1320. CrossRef